Polycystic Ovarian Syndrome Treatment Market Size

Polycystic Ovarian Syndrome Treatment Market Size

Polycystic Ovarian Syndrome Treatment Market was valued at USD 5.6 billion in 2023 and is anticipated to witness growth at a CAGR of 5.8% over the analysis period. The increasing prevalence of PCOS, attributed to lifestyle changes and rising obesity rates, has led to a greater demand for treatments.

For instance, as per the National Institute of Health (NIH), the estimated global prevalence of PCOS among women of reproductive age (15–49 years) is between 5% and 15%. Increasing number of women being diagnosed with PCOS, increases the demand for effective medications, thereby boosting the market growth. Additionally, enhanced awareness and diagnosis of the condition have further expanded the patient pool seeking medical intervention. Furthermore, the growing emphasis on women's health and fertility, alongside the expansion of healthcare infrastructure in emerging markets, also significantly contributes to the market's expansion.
 

Polycystic ovarian syndrome (PCOS) treatment refers to the medical management and therapeutic strategies used to alleviate symptoms and address the underlying hormonal imbalance in individuals with PCOS. PCOS is a common endocrine disorder characterized by irregular menstrual cycles, hyperandrogenism (excess levels of male hormones), and polycystic ovaries. The treatment for PCOS is typically tailored to the patient's symptoms, reproductive goals, and overall health.